(Total Views: 870)
Posted On: 08/04/2025 7:31:31 PM
Post# of 155732

"The decline in circulating tumor cells (“CTCs”) observed in most patients after as little as **....one dose of leronlimab**..... was significantly associated with both progression-free and overall survival.
& .....
"Confirming the full extent of leronlimab’s activity on the primary tumor is on our short list of clinical priorities in the coming months."
___
That....is why the recent filings
Just like I said on 7/27/2025:
https://investorshangout.com/post/view?id=6779023
There is no way we do not prove & get historically credited with the MOA that has changed humanity.
& .....
"Confirming the full extent of leronlimab’s activity on the primary tumor is on our short list of clinical priorities in the coming months."
___
That....is why the recent filings
Just like I said on 7/27/2025:
https://investorshangout.com/post/view?id=6779023
There is no way we do not prove & get historically credited with the MOA that has changed humanity.

